Medecins Sans Frontieres, Netherlands
Quick facts
Marketed products
- AA(FDC) · Infectious Disease
AA(FDC) is a fixed-dose combination antimalarial therapy containing artesunate and amodiaquine that works by disrupting parasite metabolism and preventing malaria infection. - AL · Rheumatology
Allopurinol works by inhibiting the enzyme xanthine oxidase, which is involved in the production of uric acid. - AM(FDC) · Neuroscience
- AM(LT) · Neuroscience
am(lt) is a small molecule that works by interacting with a specific target in the body, but its exact mechanism is unknown. - DP · Infectious diseases
DP is a medication used to treat certain types of infections caused by bacteria.
Phase 2 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Medecins Sans Frontieres, Netherlands portfolio CI brief
- Medecins Sans Frontieres, Netherlands pipeline updates RSS
Frequently asked questions about Medecins Sans Frontieres, Netherlands
What are Medecins Sans Frontieres, Netherlands's marketed drugs?
Top marketed products include AA(FDC), AL, AM(FDC), AM(LT), DP.